Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_1
1
33%
Ph phase_2
2
67%

Phase Distribution

1

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 2Efficacy & side effects
2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Other(1)

Detailed Status

Not yet recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 11 (33.3%)
Phase 22 (66.7%)

Trials by Status

not_yet_recruiting267%
unknown133%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruitingphase_2

The Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Mild to Moderate Alzheimer's Disease

NCT06840054
not_yet_recruitingphase_2

Efficacy of OsteoBor in Postmenopausal Osteoporosis

NCT06809816
unknownphase_1

Safety and Efficacy of Sodium Pentaborate Pentahydrate in People With Overweight and Obesity

NCT05741606

Clinical Trials (3)

Showing 3 of 3 trials
NCT06840054Phase 2

The Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Mild to Moderate Alzheimer's Disease

Not Yet Recruiting
NCT06809816Phase 2

Efficacy of OsteoBor in Postmenopausal Osteoporosis

Not Yet Recruiting
NCT05741606Phase 1

Safety and Efficacy of Sodium Pentaborate Pentahydrate in People With Overweight and Obesity

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3